Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters











Database
Language
Publication year range
1.
Ann Diagn Pathol ; 15(5): 312-7, 2011 Oct.
Article in English | MEDLINE | ID: mdl-21652246

ABSTRACT

Malignant tumors of the uterine corpus are uncommon. They originate from the endometrial stroma, smooth muscle, blood vessels, or from a mixture of them. The objective of this article was to know the frequency and the clinical, morphologic, and immunophenotype characteristics of the endometrial stromal sarcoma (ESS). We reviewed the cases of ESS observed from 2002 to 2008 at the Pathology Unit of the General Hospital of Mexico. The following data were analyzed: age, clinical stage, degree of differentiation, and immunophenotype. We found 18 cases, and the average age of patients was 48.6 years; 66% were in clinical stages 1 and 2. Fifteen cases (83.3%) were classified as low-grade sarcomas and 3 (16.6%) as high-grade or undifferentiated sarcomas. We determined immunohistochemical markers in 17 cases; receptors to estrogens were positive in 5 (29.4%) and to progesterone in 9 (52.9%). CD10 was expressed in 10 (58.8%) and p53 in 11 cases (64.7%). Two cases were associated to primary tumors of the ovary (papillary cystadenocarcinoma). In conclusion, ESS was present at 0.6% in our institution; and most were low grade. Expression of markers, such as p53, CD10, and hormonal receptors, was positive.


Subject(s)
Endometrial Neoplasms , Sarcoma, Endometrial Stromal , Adult , Age Factors , Age of Onset , Biomarkers, Tumor/analysis , Endometrial Neoplasms/metabolism , Endometrial Neoplasms/pathology , Endometrial Neoplasms/physiopathology , Female , Humans , Immunophenotyping , Middle Aged , Neoplasm Staging , Neoplasms, Second Primary/metabolism , Neoplasms, Second Primary/pathology , Neoplasms, Second Primary/physiopathology , Neprilysin/analysis , Neprilysin/metabolism , Ovarian Neoplasms/metabolism , Ovarian Neoplasms/pathology , Ovarian Neoplasms/physiopathology , Receptors, Estrogen/analysis , Receptors, Estrogen/metabolism , Receptors, Progesterone/analysis , Receptors, Progesterone/metabolism , Sarcoma, Endometrial Stromal/metabolism , Sarcoma, Endometrial Stromal/pathology , Sarcoma, Endometrial Stromal/physiopathology , Tumor Suppressor Protein p53/analysis , Tumor Suppressor Protein p53/metabolism
2.
Ann Diagn Pathol ; 8(5): 295-8, 2004 Oct.
Article in English | MEDLINE | ID: mdl-15494937

ABSTRACT

Endometrial stromal sarcoma is a rare neoplasm of the uterus. Extrauterine locations of this neoplasm, excluding metastases or local extension, are even more unusual and are usually associated with the presence of endometriosis. The authors report a case of endometrial stromal sarcoma presenting as a vaginal wall nodule, without any sign of primary uterine tumor after extensive evaluation or presence of endometriosis. The morphology, immunohistochemical profile, differential diagnoses, and pathogenesis are discussed, as well as a review of the literature on this issue.


Subject(s)
Endometrial Neoplasms/pathology , Sarcoma, Endometrial Stromal/pathology , Vaginal Neoplasms/pathology , Adult , Antigens, CD/metabolism , Biomarkers, Tumor/metabolism , Diagnosis, Differential , Disease-Free Survival , Endometrial Neoplasms/metabolism , Endometrial Neoplasms/surgery , Female , Humans , Immunohistochemistry , Receptors, Estrogen/metabolism , Receptors, Progesterone/metabolism , Sarcoma, Endometrial Stromal/metabolism , Sarcoma, Endometrial Stromal/surgery , Semaphorins/metabolism
SELECTION OF CITATIONS
SEARCH DETAIL